Bristol-Myers Squibb News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

24.06.21	Prothena To Receive $80 Mln From Bristol Myers For US License To PRX005 On Alzheimer's Disease (RTTNews)
18.06.21	Bristol Myers Enters Into Collaboration For Eisai's MORAb-202 Antibody Drug Conjugate (RTTNews)
14.06.21	Exelixis, Bristol Myers To Evaluate XL092-Immuno-oncology Therapies In Advanced Solid Tumors (RTTNews)
11.06.21	BMY, Acceleron Announce New Data From Reblozyl Phase 2 Trial For Adults With NTD Beta Thalassemia (RTTNews)
10.06.21	BMY Reports Positive Results From Phase 3 Breyanzi Trial In Second-line Relapsed Or Refractory LBCL (RTTNews)
02.06.21	Health Canada Approves Bristol Myers' Opdivo Plus Yervoy To Treat Mesothelioma - Quick Facts (RTTNews)
02.06.21	EC Approves Bristol Myers' Opdivo Plus Yervoy To Treat Mesothelioma - Quick Facts (RTTNews)
25.05.21	Xencor, Bristol Myers Ink License Deal To Use Xtend XmAb Technology To Treat COVID-19 - Quick Facts (RTTNews)
18.05.21	Agenus Grants Bristol Myers Squibb License To Bispecific Antibody Program, AGEN1777 - Quick Facts (RTTNews)
29.04.21	Bristol Myers Squibb Q1 Profit Misses Estimates (RTTNews)
23.04.21	Bristol Myers Gets Positive CHMP Opinion For Opdivo Plus Yervoy As First-Line Treatment For MPM (RTTNews)
19.04.21	First FDA-approved Immunotherapy For First Treatment Of Gastric Cancer (RTTNews)
14.04.21	Bristol Myers' Nivolumab Approved By EU For Kidney Cancer Treatment (RTTNews)
29.03.21	FDA Approves First Cell-Based Gene Therapy For Adult Multiple Myeloma Patients (RTTNews)
27.03.21	Biotech Stocks Facing FDA Decision In April 2021 (RTTNews)
25.03.21	Bristol Myers Squibb Announces Positive Results For Relativity-047 Study- Quick Facts (RTTNews)
12.03.21	AVEO, Bristol Myers To Evaluate Fotivda - Opdivo In Phase 3 Trial In Relapsed Renal Cell Carcinoma (RTTNews)
16.02.21	Bristol-Myers, Sanofi Ordered To Pay $834 Mln Over Plavix In Hawaii (RTTNews)
08.02.21	FDA OKs Bristol-Myers Squibb's Breyanzi To Treat Large-B-Cell Lymphoma (RTTNews)
04.02.21	Bristol-Myers Squibb Co. Q4 adjusted earnings Beat Estimates (RTTNews)
04.02.21	Bristol Myers Squibb Raises 2021 Adj. Earnings Guidance (RTTNews)
11.01.21	Amgen, AstraZeneca, Bristol Myers Squibb To Evaluate GRAIL's Cancer Early Detection Test (RTTNews)
11.01.21	Bristol Myers Board Authorizes Incremental Share Repurchase - Quick Facts (RTTNews)
05.01.21	Evotec Receives $6 Mln Payment From Bristol Myers On IPSC-based Neuroscience Partnership (RTTNews)
28.12.20	Bristol Myers Squibb: EMA Validates Marketing Authorization Application For Zeposia (RTTNews)
28.12.20	Biotech Stock Picks That Delivered Triple-digit Gains - Is There More Room To Run? (RTTNews)
23.12.20	Bristol-Myers: Phase 3 CheckMate -548 Trial Will Not Meet Primary Endpoint Of Overall Survival (RTTNews)
17.12.20	Evotec Meets Key Milestones In Partnership With Bristol Myers On Targeted Protein Degradation (RTTNews)
11.12.20	Bristol Myers' Celgene, Cipla Settle U.S. Patent Litigation On Lenalidomide (RTTNews)
23.11.20	Schrdinger Enters Into Discovery Collaboration With Bristol Myers Squibb - Quick Facts (RTTNews)
17.11.20	Bristol Myers Squibb Completes Acquisition of MyoKardia, Strengthening Company’s Leading Cardiovascular Franchise (Businesswire)
17.11.20	ADMP Snubbed Again, FDA Delay's Decision On BMY's Liso-cel, MRNA's COVID-19 Vaccine 94.5% Effective (RTTNews)
15.11.20	Week Ahead In Pharma: FDA Decisions, Data Readouts (ADMP, EIGR, KZIA, AVRO…) (RTTNews)
05.11.20	Bristol Myers Squibb Raises FY20 Earnings Guidance - Quick Facts (RTTNews)
04.11.20	Bristol Myers - MyoKardia Deal Receives U.S. Regulatory Approval (RTTNews)
04.11.20	Bristol Myers Squibb and MyoKardia Announce Expiration of HSR Act Waiting Period (Businesswire)
02.11.20	Will Eiger's Zokinvy Make History To Become First-ever Progeria Treatment? (RTTNews)
26.10.20	Biotech Stocks Facing FDA Decision In November 2020 (RTTNews)
08.10.20	Evotec, Bristol Myers Expand Neuroscience Partnership; Evotec Gains Milestone Payment (RTTNews)
07.10.20	Opdivo Plus Chemotherapy As Neoadjuvant Treatment In Resectable NSCLC Trial Hits Key Goal, Says BMY (RTTNews)
07.10.20	Canada Approves Bristol-Myers' Zeposia To Treat Relapsing Remitting Multiple Sclerosis (RTTNews)
05.10.20	Bristol Myers Snaps Up MyoKardia For $225/Share (RTTNews)
05.10.20	Bristol Myers Squibb To Buy MyoKardia For $13.1 Bln In Cash - Quick Facts (RTTNews)
05.10.20	Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash (Businesswire)
05.10.20	FDA Approves Drug Combination To Treat Mesothelioma (RTTNews)
29.09.20	Bristol Myers, Acceleron Pharma Announce Health Canada Approval Of Reblozyl (RTTNews)
17.09.20	Celgene, Dr. Reddy's Reach Settlement Agreement On Patents For REVLIMID Capsules (RTTNews)
27.08.20	Biotech Stocks Facing FDA Decision In September (RTTNews)
06.08.20	Bristol-Myers Slips To Loss In Q2, But Results Top Estimates (RTTNews)
06.08.20	Pre-market Movers In Healthcare Sector: AVXL, BEAM, AVGR, BMY... (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

26.11.24		Verluste in New York: Dow Jones legt den Rückwärtsgang ein
26.11.24		Schwache Performance in Europa: Euro STOXX 50 schlussendlich leichter
26.11.24		Schwache Performance in Frankfurt: LUS-DAX letztendlich in Rot
26.11.24		DAX aktuell: DAX beendet die Dienstagssitzung mit Verlusten
26.11.24		Börse Zürich: SMI letztendlich in Rot
26.11.24		Dow Jones 30 Industrial-Papier Merck-Aktie: Wäre eine Merck-Investition von vor einem Jahr lukrativ gewesen?
26.11.24		S&P 500-Wert Pfizer-Aktie: So viel Verlust wäre bei einem Investment in Pfizer von vor einem Jahr angefallen
26.11.24		Schwacher Handel in New York: Dow Jones zum Start mit Abgaben

26.11.24

Verluste in New York: Dow Jones legt den Rückwärtsgang ein

26.11.24

Schwache Performance in Europa: Euro STOXX 50 schlussendlich leichter

26.11.24

Schwache Performance in Frankfurt: LUS-DAX letztendlich in Rot

26.11.24

DAX aktuell: DAX beendet die Dienstagssitzung mit Verlusten

26.11.24

Börse Zürich: SMI letztendlich in Rot

26.11.24

Dow Jones 30 Industrial-Papier Merck-Aktie: Wäre eine Merck-Investition von vor einem Jahr lukrativ gewesen?